August 2013


mobile health and telemedicine, all of which is quickly becoming a major field and there is much demand among start-ups to understand this quickly developing market. We are planning several sessions on such topics as Smartphone medical applications, transmission secu- rity, implantable sensors etc.


The ICI meeting attracts cardiologists, innovative scientists, biomedical engineers, financial investors and representatives from the medical industry—over 1,000 attendees.


What are the specific themes of this year’s meeting?


Among other themes, this year we are concentrating on the brain as the next target for future interventions as well as the on-going revolution of digital connected health and autonomic sympathetic modulation. The ICI Innovation of the Year Award is the among world’s most prestigious awards for medical intervention Startups. Final- ists have the opportunity to meet with a world-class panel of clinical and com- mercial experts face-to-face, and have to prove the merit of their idea—and receive valuable advice and guid-


ance in the process, which is an opportunity that money cannot buy. Winning an ICI Innovation Award offers unparalleled clinical and commercial validation, as well as valuable exposure to an international audience that should help spur investors and other interested parties to take note of the innovation, and help it progress towards benefiting patients.


As someone who has been involved with several innovations, what advice would you give to an interventional cardiologist about how they can develop an idea into an actual product? Team up with the best people available and never give up. We have not yet entered significantly into the field of brain interventions, especially during acute stroke. We must conduct research to better understand the needs of patients suffering a stroke or bleeding aneurysm.


As well as ICI, you are an associate director for TCT (27 October–1 November, San Francisco, USA). What, in your view, is the value of attending medical conferences?


There are many values to attending medical conferences; inspiring mutual cooperation is one of them. The world of interven- tional cardiology is a small one and it has been advancing nicely, especially in Far Eastern countries. Gathering at a confer- ence allows professionals from diverse places worldwide to learn from each other about clinical experiences, procedures, latest


research, newest technologies and different techniques. They would not have the opportunity otherwise to meet and form so many bonds that can strengthen their own practice, while also leading to more progress and advancement in the field. This is of course in addition to the primary purpose of the conferences of providing a top-level concentrated educational experience on a wide variety of subtopics.


What has been your most memorable case and why?


I will share with you two extreme cases that describe the remarkable changes the field of interventional cardiol- ogy has undergone in the last two decades. The first occurred about 20 years ago: a relatively young gentleman came in with a small anterior myocar- dial infarction. We catheterised him a few days later and opened with a balloon in the left anterior descending ar- tery, but the patient occluded the artery a few hours later (probably due to dissection). Since all other attempts to open the artery failed, he was sent to bypass surgery. Unfortunately he barely survived the surgery due to large infarct, and after several days in the ICU, he died of heart failure without being able to find him a donor. This was a depressing case that stayed with me for a long time, together with the feeling of helplessness at not being able to save him.


On the other hand, about eight years ago, an extremely smart, active, and co- herent 92 year- old woman came in with distal tight left main disease. We did a complex PCI that allowed her to live for six more fruitful years.


I feel that these are good examples that portray where we have been, how far we have come and where we are now.


Outside of medicine, what are your hobbies and interests? Outside of medicine, I enjoy spending time with my family, going to the beach, travelling, wine tasting, and seeking out the next best invention.


Fact File Appointments


2000–present 2009 2005–present


May 2011– April 2013 1997–2000


Director of the Heart Institute, Hadassah-Hebrew University Medical Center, Jerusalem, Israel


Professor of Medicine


(Cardiology), Hebrew University- Hadassah School of Medicine, Jerusalem, Israel


David and Rose Orzen chair in Cardiology, Hebrew University- Hadassah School of Medicine, Jerusalem, Israel


President, Israel Heart Society


Director of Interventional Cardiology and Cardiac Catheterization, Hadassah University Hospital, Jerusalem, Israel


Education and training 1987–89


Clinical and Research fellow in Nuclear Magnetic Resonance, Cardiovascular Division, University of Alabama at Birmingham, USA.


1984–87 1981–84 1980 1973–79


Fellow in Cardiology, Hadassah University Medical Hospital, Jerusalem, Israel


Residency program, Department of Pediatrics, Hadassah Medical Center, Jerusalem, Israel


Rotating internship, Hadassah Medical center, Jerusalem, Israel


Hadassah Hebrew University Medical School, Jerusalem, Israel


Memberships „ Education in Cardiology Committee, European Soci- ety of Cardiology (2011–12)


„ Head of Electronic Education in Cardiology Commit- tee, European Society of Cardiology (2012)


„ Fellow of the European Society of Cardiology (since 2004)


„ Fellow of the American College of Cardiology (since 1994)


Longstanding member of: „ Israel Medical Association „Israel Heart Society „American Heart Association „ Israel Society for the Prevention of Atherosclerosis „Israel Working Group for Interventional Cardiology „ International Society for Heart Research, European Section, Israeli Subsection (Executive Board)


„ Medical Specializations Confirmation Committee of the Scientific Council of the Israeli Medical Associa- tion


„ SOS-CVD (Society of studying cardiovascular diseases)


Awards 2006


2003 2003


TCT Most Challenging Case in Operator Tutorial, Cardiovascular Research Foundation


PCR Call for Cases Awards (3rd prize)


CYPHER Stent Investigator Award, Cordis Johnson &Johnson Corporation


Interview


21


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40